Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My son’s is covered, but since there are no generics available, it still costs $397/month,at least his last prescription.
Thx. That makes sense if it’s for brand, but never heard of generics not being covered for Rx in adult space.
LoL LoL ............ NasRat is not to be worshipped !!!!!!!!!!!!!!!!!!!!!!!!!!
IB_🤴🏻
Hang in there brah, you may get your wish by mid-June !!!!!!!!!!!!!!!!!!!!!!!!!!!!!
IB_🤴🏻
Quote: "we don’t have the best CEO" !!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 💯# CORRECT
Day'Um Scrate we don't,
IB_🤴🏻
Thank you. GAPS always get filled! Don't ever listen to King as he sold his soul to buy above the gap and was persuading people that the gap would not happen! He even persuaded people not to buy at 3 and 4! Then when he bought at 10, he was putting people down again! Just insane! We know what we have! GLTU. Really enjoy reading your take on it all.
CMDawg, Good Luck! I hope you get a nice ROI on that trade. You were right about the gap filling.
Since you have no idea why you are required to be on this board, and it is obvious you just pull from people's messages to act like you know something. So obviously you are here on the job. But why?
It's pretty funny
Most insurances cover ADHD meds for adults. Some may need prior approval, especially the more expensive ones (e.g. Vyvanse brand).
You are too much of an AH for me to waste time answering you
I checked - Nasrat is OK - Not in Jail.
However, not sure about the self crowned King. He disappeared - maybe he doe not have Internet access there?
Don't they have a library to try to connect?
Do you troll political boards too? Does it pay the same?
They gave them all to me at .124. I’ll take them
Going to buy 80000 shares at .125. Higher then the current ask. Let’s see what I get.
You still didn’t answer my question What did I say that isn’t true You are like a snowflake When someone disagrees with you , you want them shut down Yoy probably got a lot of participation trophy’s I probably have more invested in this than you Grow up you little sissy
Any pharmacists running into insurance issues covering adult ADHD Rx? First I’ve heard of this.
“When I picked up my prescription, the pharmacist explained that a lot of insurers didn't want to cover adult ADHD prescriptions.”
https://reason.com/2024/04/23/it-took-me-months-to-get-the-adhd-meds-the-dea-says-are-overprescribed/
A current stock’s price in pennyland dictates nothing, especially after a 600% run!!
Eltp
Got my baited hook in the water to catch some cheap fishies!!!!!!
Agreed, regardless of what stock price dictates.
You don't believe, move on!! With all your belly aching, you don't deserve to make any $$$s!! Out with you! People invest because they believe. If you can not afford to lose, you should not invested. This is all on you!!
I guess. Historically, they haven’t really.. at least not that I can recall. Possibly a little bit more volume just due to a positive PR of some kind. Every drug approval and launch though, large or small, puts us in better financial position regardless of PPS reaction.
Small ones would at least put some life into the stock.
I think the accumulative 40% drop is also the nature of very to little volume and there have been a few decent size sellers since last call. Price has slowly drifted down with anticipation of no news driving new volume. Waiting for Q4 results is like the dead zone in the Gulf of Mexico.
Ehh. I hear this too but at the same time, I think most here would say the smaller drugs would have little to no impact upwards on share price if approved on time. So almost no upside, all downside?
I understand your post but at the same time, a 40% drop in price is warranted from the best quarter in the company’s long history? Every day means we’re closer to the 2nd facility opening up and more drugs being approved and launched. The price here makes no sense.
Definitely agree on 2 small drugs not getting approved and PE ratio getting ridiculously low. Great buying opportunity for what is potentially in store.
It was the best sales Q, but didn’t live up to the hype CEO created. That was him putting his foot in his mouth yet again. Agree to disagree. Had they hit it out of the park with revenue last Q week wouldn’t be where we are today.
lol I’m sorry you sing praises to the CEO and worship him. He has made many mistakes in the past. I’m sorry you can’t see this. I could care less if I’m ignored.
Agree that Prasco should be bigger. It still can as the Dec sales was a single, kick off shipment. We don't know if it is the typical size of a typical quarters manufacturing level for Prasco. Drop is also because approval of 2 drugs with combined market value of about $50 million did not occur on expected timeline. That may have bothered some investors in that it illustrates that drug approvals can't be taken for granted and that a submission doesn't really have value unless/until its approved.
PE is getting really low, with two months left an amazing buy opportunity could come up if some with large holdings decide to liquidate. Definitely keeping my eye out to take advantage of such impatience.
A slow drip of 40% decrease in share price on little daily volume is due to the best sales quarter in history not being great enough due to a slower start with Prasco than expected. Disagree
That’s it. Ignored.
WTH?
It’s not worth that much today and we don’t have the best CEO, but he should be good enough to get the job done and lead us to a buyout if we can get the pending and upcoming anticipated drugs approved and launched successfully.
Q3 was not as big of a pickup from Prasco as CEO conveyed during Q2. I think the drop is whether Prasco is as big of a deal as anticipated. We’ll know in couple months.
Why would I move on buddy Because I don’t agree with you I’m entitled to my position What did I say that isn’t true ?
What developments with Elite the company justify that drop? Can you point to any?
great for adding 50K mord
Whats amazing is you watching this go from 2 cents to 21 cents.
I thought ELTP might get a bounce after closing the gap but behold, it closed down 3%
Thoughts?
Isn't it more amazing that you have been on this board for years and have no idea why? Except that you were assigned to be here. Now that is truly funny.
As far as the company. The company has amazing financials and it's just starting. Not sure if you know that since you have no idea why you are here anyway and can only pick pieces of people's messages to say something not actually knowing anything on your own. Maybe your boss can write something for you?
We NasRat Worshipers are always Topping-Off and Adding More for the Big $0.25 Buyout in 21 months !!!!!!!!!!!!!!!!!!!!!!!!!!!
Why are you here ?????????? Who do you work for ?????????? Is it bedtime on your planet ??????????
Goat, Goat, Goat .................... Keep working for us NasRat worshipers and bring the price down so we can sell a pint of Goat milk and buy 3 more shares plus pay the commission,
IB_🤴🏻
I find it amazing that this best company on the OTC that’s going to be worth 2, 3, 4 dollars a share ( but hasn’t been over 25 cents in 10 years) and has the best CEO ever can loose about half its value in the past 2months and all you hear is NOTHING!!! How about a word from the company that all is well You know why Cause all is not well !!! Something is very wrong here
So......still dropping,
"BuyA Thon" ??
Who's buying ??
Blow hard lottery club member with " million$"
could help this sinking ship.
LOFL.
You have to be realistic about this thing at some point. Hype and hope strategy is not working.
Last post, have a good day
BuyA Thon is starting.
GLTY
I Filled that gap Twice now
$$$
2.5 more cents. Remember, you work for Daddy, now.
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite Dexcel |
Adderall XR | 1.56 B | On Market | 10 | Elite Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 47 M | On Market | 5 | Elite |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | 4 | ---------- |
Vyvanse | 4.70 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |